ProPhase Labs Q3 EPS $(0.30) Misses $(0.20) Estimate, Sales $8.37M Miss $13.06M Estimate
Portfolio Pulse from Benzinga Newsdesk
ProPhase Labs reported Q3 losses of $(0.30) per share, missing the analyst consensus estimate of $(0.20) by 50%. This is a 600% decrease over earnings of $0.06 per share from the same period last year. The company also reported quarterly sales of $8.37 million, missing the analyst consensus estimate of $13.06 million by 35.95%. This is a 65.43% decrease over sales of $24.20 million the same period last year.
November 09, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ProPhase Labs reported a significant decrease in Q3 earnings and sales, missing analyst estimates. This could negatively impact the company's stock price in the short term.
ProPhase Labs reported a 600% decrease in earnings and a 65.43% decrease in sales compared to the same period last year, missing analyst estimates. This underperformance is likely to negatively impact investor sentiment and could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100